DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/Chroma Medicine
activeFounded 2021

Chroma Medicine

HQ: Cambridge, MA, USACEO: Catherine Stehman-BreenHeadcount: 100+chromamedicine.com
Funding Summary
Total Funding
$260M+
Latest Valuation
Undisclosed
About

Pioneering epigenome editing — silencing or activating genes without cutting DNA by modifying epigenetic marks, avoiding permanent DNA changes.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →